给予尼古丁可抑制动物模型中的近视生长
该研究在雏鸡中观察了尼古丁经玻璃体腔注射或局部滴眼对形觉剥夺性近视和透镜诱导性近视的抑制作用,并评估了眼部安全性及非眼部自主神经功能。结果显示尼古丁可显著抑制两种实验性近视的发展,但最高局部剂量可引起短暂的心肺输出下降,且尼古丁的已知副作用和成瘾性会妨碍其临床应用。
要点
- 尼古丁经玻璃体腔注射或局部滴眼均显著抑制雏鸡形觉剥夺性近视(P < 0.05),但非剂量依赖性。
- 尼古丁亦显著抑制透镜诱导性近视(P < 0.05),程度与形觉剥夺性近视相似。
- 最高局部剂量引起短暂心肺输出下降(P < 0.05),尼古丁的副作用和成瘾性会妨碍其临床应用。
核心结论
- 尼古丁经玻璃体腔注射或局部滴眼可显著抑制实验性近视的发展,但其已知副作用和成瘾性会妨碍其临床应用。
研究设计与样本
- 在雏鸡中研究尼古丁抑制形觉剥夺性近视:玻璃体腔注射每组9只、局部滴眼每组6只,各测试三个剂量。
- 在12只雏鸡中测试尼古丁抑制透镜诱导性近视的能力。
- 眼部安全性评估:局部滴眼4周后(n = 10)检查瞳孔反射、眼压、角膜曲率/厚度、晶状体厚度、视网膜健康(视网膜厚度/细胞凋亡)及视网膜功能(视网膜电图)。
- 在雏鸡(n = 5)和小鼠(n = 5)中检查尼古丁对非眼部自主神经功能的影响。
主要发现
- 尼古丁经玻璃体腔注射(P < 0.05)或局部滴眼(P < 0.05)均显著抑制雏鸡形觉剥夺性近视的发展,但非剂量依赖性。
- 尼古丁亦抑制透镜诱导性近视(P < 0.05),程度与形觉剥夺性近视相似。
- 眼部健康大部分未受尼古丁影响,但最高局部剂量引起短暂心肺输出下降(P < 0.05)。
临床怎么用
- 原文结论指出,尼古丁的已知副作用和成瘾性会妨碍其临床应用。
局限性
- 原文结论指出尼古丁的已知副作用和成瘾性会妨碍其临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While previously investigating the mechanism by which atropine inhibits ocular growth, we observed that stimulation of nicotinic receptors can inhibit experimental myopia. This study expands on that preliminary finding and investigates the safety and efficacy of nicotinic stimulation in the inhibition of ocular growth. METHODS: Nicotine's ability to inhibit form-deprivation myopia (FDM), following intravitreal injection (9 chicks per group) or topical application (6 chicks per group), was investigated over three doses. The ability of nicotine to inhibit lens-induced myopia (LIM) was also tested (in 12 chicks). For ocular safety, following 4 weeks of topical treatment with nicotine (n = 10), pupillary reflex, intraocular pressure, corneal curvature/thickness, lens thickness, retinal health (retinal thickness/cell apoptosis), as well as retinal function (electroretinogram recordings) were assessed. We also examined the effects of nicotine on non-ocular autonomic functions in both chicks (n = 5) and mice (n = 5). RESULTS: Nicotine was observed to significantly inhibit the development of FDM in chicks when administered as an intravitreal injection (P < 0.05) or topical eye drops (P < 0.05), albeit not in a dose-dependent manner. Nicotine also inhibited LIM (P < 0.05) to a similar degree to that seen for FDM. Although ocular health was (for the most part) unaffected by nicotine, the highest topical dose induced a temporary reduction in cardiorespiratory output (P < 0.05). CONCLUSIONS: Nicotine, administered as an intravitreal injection or topical eye drop, significantly inhibits the development of experimental myopia. Although the anti-myopic effects observed presently are interesting, the well-reported side effects (expanded on presently) and addictive properties of nicotine would preclude its clinical use.
引用
- Thomson K, Karouta C, Ashby R, et al. Administration of Nicotine Can Inhibit Myopic Growth in Animal Models. Invest Ophthalmol Vis Sci. 2024. PMID: 39292451. doi:10.1167/iovs.65.11.29
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。